Reaction

N-Terminal Prohormone Brain Natriuretic Peptide Increased reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 1,384 reports · 58 co-occurring drugs

As of the last recalculation, N-Terminal Prohormone Brain Natriuretic Peptide Increased appears in 1,384 FAERS reports alongside 58 co-occurring drug terms. The strongest observed disproportionality signal is EPLERENONE (PRR 140.3).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Eplerenone110140.3141.5
Axicabtagene Ciloleucel4774.174.5
Sildenafil Powder,10346.947.1
Selexipag7344.844.9
Dapagliflozin8643.843.9
Sacubitril And Valsartan24237.837.9
Torsemide7435.435.5
Sildenafil11733.133.2
Spironolactone24732.032.0
Macitentan13131.331.4
Bisoprolol Fumarate22128.929.0
Tolvaptan2627.427.4
Tafamidis2025.925.9
Epoprostenol2225.725.7
Desloratadine1825.625.6
Nebivolol2221.121.1
Apixaban8720.820.8
Metolazone1520.320.3
Fludarabine Phosphate5019.819.8
Sildenafil Citrate13717.917.9
Riociguat3717.517.5
Empagliflozin7417.417.4
Furosemide35217.417.4
Febuxostat Tablets 40 Mg1116.416.4
Febuxostat Tablets 80 Mg1116.416.4
Oxazepam2316.316.4
0Xygen4915.515.5
Oxygen4915.515.5
Amiodarone Hydrochloride1114.914.9
Clopidogrel Bisulfate8813.813.8
Leucovorin Calcium1713.513.5
Digoxin6013.113.1
Carvedilol10312.312.3
Bosentan4012.312.3
Travoprost712.212.2
Dexamethasone Sodium Phosphate811.911.9
Methimazole611.511.5
Sotalol Hydrochloride1210.910.9
Nebivolol Hydrochloride2410.910.9
Febuxostat1210.910.9
Tadalafil6510.210.2
Pemetrexed149.99.9
Cyclophosphamide Injection, Solution1069.79.7
Cyclophosphamide1069.79.7
Cyclophosphamide For Injection1069.79.7
Carfilzomib179.19.1
Atorvastatin Calcium, Film Coated419.09.0
Pitavastatin Calcium68.98.9
Daratumumab238.88.8
Amlodipine Besylate And Valsartan68.28.2
Treprostinil658.18.1
Patiromer77.67.6
Pembrolizumab517.57.5
Bortezomib417.17.1
Regorafenib56.56.5
Pemetrexed Disodium156.06.0
Ixazomib105.35.3
Alteplase55.05.0

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.